Media

Support Of Industry Underscores Pro-Business Commitment
2014 Livestock Biotech Summit three day programming touched on issues such as engaging consumers, animal welfare, the promise of the technology.

Press Releases

Jan 19 1999
WASHINGTON, D.C. (Jan. 19, 1999) Fifty-two companies will participate in the annual CEO & Investor Conference organized by the Biotechnology Industry...
Jan 15 1999
BIO has long been concerned about the possible misuse of genetic or medical information. Recent news reports about plans to collect data on the health...
Jan 15 1999
The Biotechnology Industry Organization issued the following statement from its Executive Director, Technical Affairs, Alan Goldhammer, Ph.D.: "Health...
Nov 12 1998
(WASHINGTON, D.C., November 12, 1998). . . Carl B Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...
Nov 11 1998
(WASHINGTON, D.C., November 11, 1998). . . The Biotechnology Industry Organization (BIO) will host a CEO & Investor Conference in New York Feb. 24-26,...
Oct 27 1998
(WASHINGTON, D.C., October 27, 1998). . . Colorado State Rep.Tony Grampsas (R) has been named the "Outstanding State Legislator of the Year" by the...
Oct 27 1998
(WASHINGTON, D.C., October 27, 1998). . .The Biotechnology Industry Organization (BIO), the largest association of biotechnology companies, state...
Oct 2 1998
(WASHINGTON, D.C., October 2, 1998)...The Biotechnology Industry Organization (BIO) today praised U.S. Rep. Jennifer Dunn (R-Bellevue) of Washington for...
Sep 2 1998
(WASHINGTON, DC, September 2, 1998)...Carl B.Feldbaum, president of the Biotechnology IndustryOrganization (BIO), issued the following statement inresponse...


Biotechnology News

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it has secured a $31 million term loan...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash...

October 1, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class...

October 1, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2014 after market...

October 1, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence